This would also at least partly explain why FoxP3+ Tregs seem to promote tumor-progression in some cancers, such as colorectal cancer [26–28], while inhibiting tumor growth in other cancer types, such as breast cancer [29]. Here, FOXP3 is linked to breast carcinoma.